10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342,128 | -34.7% | 8,294 | -11.6% | 0.72% | -11.5% |
| Q2 2023 | $523,891 | -8.4% | 9,382 | -8.5% | 0.81% | -2.9% |
| Q1 2023 | $571,848 | +35.8% | 10,250 | -11.3% | 0.84% | +55.8% |
| Q4 2022 | $420,991 | +0.7% | 11,553 | -21.3% | 0.54% | +30.4% |
| Q3 2022 | $418,000 | -16.2% | 14,678 | +33.1% | 0.41% | -10.5% |
| Q2 2022 | $499,000 | -25.0% | 11,029 | +26.2% | 0.46% | +27.1% |
| Q1 2022 | $665,000 | -56.2% | 8,737 | -14.3% | 0.36% | -31.6% |
| Q4 2021 | $1,519,000 | -27.9% | 10,197 | -29.6% | 0.53% | -25.1% |
| Q3 2021 | $2,108,000 | -18.0% | 14,478 | +10.2% | 0.70% | -25.2% |
| Q2 2021 | $2,572,000 | +11.2% | 13,133 | +2.8% | 0.94% | -8.5% |
| Q1 2021 | $2,312,000 | – | 12,773 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |